Pierre‐Yves Benhamou

The Diabeo Software Enabling Individualized Insulin Dose Adjustments Combined With Telemedicine Support Improves HbA1c in Poorly Controlled Type 1 Diabetic Patients

G. Charpentier, Pierre‐Yves Benhamou, Dured Dardari et al. · Diabetes Care · 2011 · 298 citations · Full text

Medicine, Clinical Pharmacy, Health Informatics +17

A Glycemia Risk Index (GRI) of Hypoglycemia and Hyperglycemia for Continuous Glucose Monitoring Validated by Clinician Ratings

David C. Klonoff, Jing Wang, David Rodbard et al. · Journal of Diabetes Science and Technology · 2022 · 276 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Human Bone Marrow Mesenchymal Stem Cells Can Express Insulin and Key Transcription Factors of the Endocrine Pancreas Developmental Pathway upon Genetic and/or Microenvironmental Manipulation In Vitro

Christine Moriscot, Florence de Fraipont, Marie‐Jeanne Richard et al. · Stem Cells · 2005 · 258 citations · Full text

Life Sciences, Cell Biology, Developmental Biology +14

Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial

Pierre‐Yves Benhamou, Sylvia Franc, Yves Reznik et al. · The Lancet Digital Health · 2019 · 210 citations · Full text

Medicine, Endocrinology, Internal Medicine +17

Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial

Sandrine Lablanche, Marie‐Christine Vantyghem, Laurence Kessler et al. · The Lancet Diabetes & Endocrinology · 2018 · 192 citations

Medicine, Endocrinology, Surgery +17